Earnings
AGF Management Misses Q3 Estimates as Institutional Redemptions Weigh on Results
Asset manager reported adjusted EPS of CAD 0.49 versus CAD 0.58 consensus, while revenue of CAD 112.5 million lagged forecasts by roughly 30%. Shares fell in premarket trading.
Fonix Raises FY2026 Profit Forecasts, Shares Hold Near Highs
Fonix posted adjusted EPS of $0.059, beating estimates, driven by 12.8% gross-profit growth and expanding mobile-payments volumes across five European markets.
AGF Q3 Earnings Miss as Assets Surge 31% to $74.2 Billion
Toronto-based AGF Management reported a third-quarter profit miss and weak revenue as fee compression weighed on results, though AUM jumped 31% driven by alternatives growth.
Escalade reports $240m 2025 sales, eyes double‑digit EBITDA margins
The small‑cap outdoor and sporting‑goods maker posted net sales of $240 million in 2025, net income of $13.7 million and a 26.9% net margin, while targeting 30% gross margins and debt‑free status by year‑end.
Quadient H1 2026 Earnings Reflect Digital Growth, Improved Cash Flow
Quadient reported H1 2026 earnings with EUR 448 million in revenue, driven by digital growth and improved cash flow, as it continues to divest its lockers business.
Judges Scientific H1 2026 Profit Drops Amid Revenue Decline
Revenue fell 21% year-over-year as cost cuts and order recovery partially offset losses, while analysts project cautious growth ahead.
Soul Patts H2 2026 Profit Surges 502% as Shares Rise
Soul Patts reported a 502% increase in statutory net profit after tax for the 12-month period ending July 31, 2026, driven by the AUD 15 billion Brickworks merger. Shares rose 7.14% to AUD 48.76.
CVS Group reports 5.9% revenue rise as shares fall 5.7%
The UK veterinary services firm posted 5.9% higher revenue and 5.1% higher adjusted EBITDA for FY2026, but its stock slipped to £1,228, down 5.67% on the day.
Vistry Reports H1 Loss as Overhaul Targets Capital-Light Model
UK homebuilder posts £36.2m operating loss on £578m exceptional charges, unveils strategic pivot to partner-funded model with five-year overhaul roadmap.
OVS H1 2026 Sales Rise 11% as Goldenpoint Boosts Margins
Italian retailer OVS reported consolidated net sales of about EUR 900 million in the first half, up 11%, driven by Goldenpoint integration and organic growth of 6%.
TurboGen Reports $7.2M Cash Position, Posts $4.2M Loss in First Half
Israel-based microturbine developer raises $5M in private placement and completes first unit assembly; shares begin Nasdaq trading in August.
OVS H1 Sales Surge 11%, Margins Expand on Turnaround Push
Italian fashion retailer OVS reported €877.4M in H1 consolidated net sales, up 10.7%, with EBITDA margin rising 19 basis points to 13.0% as the company exits a two-year market slump.
OVS H1 2026: Net sales rise 10.7%, EBITDA margin expands to 13%
Italian apparel retailer OVS reported H1 2026 consolidated net sales of €877.4 million, up 10.7% year-over-year, with EBITDA reaching €114.3 million and adjusted net debt declining by €53.6 million.
Milestone Pharmaceuticals enrolls first Canadian patient in AFib Phase 3 trial
The biotech's etripamil nasal spray moves into a 150-patient Phase 3 study for atrial fibrillation with rapid ventricular rate, pursued via a single-study NDA pathway.
Absci Plans Mid-2027 Phase 2 Trial of Endometriosis Drug ABS-201
The clinical-stage biopharmaceutical plans a dose-ranging study of its AI-engineered anti-prolactin receptor antibody in roughly 150 patients.
Lisata to Present MAR001 Phase 2b Trial Data at AHA Conference
Marea Therapeutics, a Lisata subsidiary, will report late-breaking results from its TYDAL study on ANGPTL4 inhibition at the American Heart Association Scientific Sessions in Chicago.
Mobix Labs Forecasts Q4 Revenue Above Guidance Midpoint
The Irvine-based electronic components maker expects fourth-quarter 2026 revenue to exceed $1.6 million, surpassing the midpoint of its prior $1.4‑$1.8 million range, driven by stronger wireless systems and defense demand.
Uxin Q2 2026 Revenue Surges 75% YoY, Stock Climbs 11% in Premarket
The Chinese used‑car platform reported CNY 1.151 billion in revenue for the quarter ended June 30 2026, driven by an 89% jump in retail vehicle transactions, while its shares rose 11.14% to $1.211 in premarket trade.
Pasqal posts 14% revenue rise in H1 2026 as operating loss widens
The quantum‑computing firm reported EUR 4.9 million revenue, up 14% YoY, while operating loss grew to EUR 59.2 million; cash balances rose to EUR 110.8 million and shares slipped 2.3% pre‑market.
BlackBerry Beats Q2 Estimates, Lifts Full-Year Guidance on Record QNX Revenue
BlackBerry reported Q2 adjusted EPS of 7 cents, beating estimates by 75%, and raised full-year revenue guidance to $616M–$636M driven by record QNX quarterly revenue of $80 million.
Verbio Reports Stronger Q4 Results; Biofuels Producer Skids in Premarket Trade
German biofuels maker Verbio posted fourth-quarter EBITDA of EUR 88.2 million, snapping a year-ago loss, but shares fell 0.8% premarket after full-year guidance missed investor expectations.
Kri-Kri Raises Full-Year Sales View but Trims Profit Outlook After H1 Surge
Greek dairy maker Kri-Kri reported H1 2026 sales of €204M, up 26%, driven by yogurt export growth, but cost pressures lead it to lower its full-year EBIT guidance.
Alten H1 Revenue Beats Forecast; Shares Rise 6.5%
Engineering services firm Alten reported H1 2026 revenue of €2.01 billion and raised full-year organic growth guidance to 1.7%-1.9%, sending shares up 6.5%.
ALTEN H1 2026 profit jumps 38% as margins improve
French engineering firm ALTEN posted a 38% rise in net income to €113.8 million in the first half of 2026, lifted operating margin to 8.9% and raised full‑year guidance.
